Sangamo Therapeutics, Inc.Sangamo Therapeutics, Inc.Sangamo Therapeutics, Inc.

Sangamo Therapeutics, Inc.

No trades
See on Supercharts

SGMO fundamentals

Sangamo Therapeutics, Inc. earnings per share and revenue

SGMO earnings per share for the last quarter are 0.04 USD whereas the estimation was -0.02 USD which accounts for 362.30% surprise. Company revenue for the same period amounts to 49.40 M USD despite the estimated figure of 20.92 M USD. Estimated earnings per share for the next quarter are -0.09 USD, and revenue is expected to reach 10.38 M USD. Also watch annual changes over time to get a bigger picture of SGMO earnings per share and revenue dynamics.

Next report date
Report period
EPS estimate
Revenue estimate
EPS
‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise
Revenue
‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise